We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBIG
2876
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$17K ﹤0.01%
1,870
+184
+11% +$2.83K
GRNA
2877
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$16K ﹤0.01%
13,492
+2,516
+23% +$4.1K
CELU icon
2878
Celularity
CELU
$20M
$14K ﹤0.01%
1,120
+96
+9% +$1.77K
LOCL icon
2879
Local Bounti
LOCL
$26M
$14K ﹤0.01%
+774
New +$24.1K
ML
2880
DELISTED
MoneyLion Inc.
ML
$14K ﹤0.01%
739
PEAR
2881
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$14K ﹤0.01%
11,499
+1,099
+11% +$2.31K
BKKT icon
2882
Bakkt Inc
BKKT
$331M
$13K ﹤0.01%
449
CENN icon
2883
Cenntro
CENN
$8.41M
$13K ﹤0.01%
51
HYMC icon
2884
Hycroft Mining Holding Corp
HYMC
$2.46B
$13K ﹤0.01%
2,469
+387
+19% +$2.47K
MAPS
2885
DELISTED
WM TECHNOLOGY INC A
MAPS
$13K ﹤0.01%
12,822
+614
+5% +$887
TDUP icon
2886
ThredUp
TDUP
$415M
$13K ﹤0.01%
10,134
-24,371
-71% -$33.4K
LTCH
2887
DELISTED
Latch, Inc. Common Stock
LTCH
$13K ﹤0.01%
18,321
+3,291
+22% +$3.02K
SPPI
2888
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$13K ﹤0.01%
34,751
-601
-2% -$253
AVYA
2889
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$13K ﹤0.01%
65,002
-52,128
-45% -$58.3K
HZN
2890
DELISTED
Horizon Global Corporation
HZN
$12K ﹤0.01%
31,760
TONX
2891
TON Strategy Co
TONX
$155M
$10K ﹤0.01%
7
-16
-70% -$28.9K
PDYN icon
2892
Palladyne AI
PDYN
$312M
$10K ﹤0.01%
2,842
HLGN
2893
DELISTED
Heliogen, Inc.
HLGN
$10K ﹤0.01%
401
DOMA
2894
DELISTED
Doma Holdings, Inc.
DOMA
$10K ﹤0.01%
914
+218
+31% +$2.47K
BODI icon
2895
The Beachbody Company
BODI
$47M
$9K ﹤0.01%
342
+46
+16% +$2K
DS
2896
DELISTED
Drive Shack Inc.
DS
$9K ﹤0.01%
51,350
ATER icon
2897
Aterian
ATER
$5.22M
$8K ﹤0.01%
881
RGTI icon
2898
Rigetti Computing
RGTI
$6.27B
$8K ﹤0.01%
+10,655
New +$15.2K
TIL icon
2899
Instil Bio
TIL
$49.7M
$7K ﹤0.01%
555
+13
+2% +$642
APPH
2900
DELISTED
AppHarvest, Inc. Common Stock
APPH
$7K ﹤0.01%
12,171

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.